<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jia J</submitter><funding>Natural Science Foundation of Fujian Province</funding><funding>Natural Science Foundation of Fujian Province (Fujian Provincial Natural Science Foundation)</funding><pagination>2473</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11903786</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Blockade of the glucagon receptor (GCGR) has been shown to improve glycemic control. However, this therapeutic approach also brings side effects, such as α-cell hyperplasia and hyperglucagonemia, and the mechanisms underlying these side effects remain elusive. Here, we conduct single-cell transcriptomic sequencing of islets from male GCGR knockout (GCGR-KO) mice. Our analysis confirms the elevated expression of Gcg in GCGR-KO mice, along with enhanced glucagon secretion at single-cell level. Notably, Vgf (nerve growth factor inducible) is specifically upregulated in α cells of GCGR-KO mice. Inhibition of VGF impairs the formation of glucagon immature secretory granules and compromises glucagon maturation, lead to reduced α-cell hypersecretion of glucagon. We further demonstrate that activa</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Blockade of glucagon receptor induces α-cell hypersecretion by hyperaminoacidemia in mice.</pubmed_title><pmcid>PMC11903786</pmcid><funding_grant_id>2023I0002</funding_grant_id><pubmed_authors>Jin Q</pubmed_authors><pubmed_authors>Kang Q</pubmed_authors><pubmed_authors>Jiang F</pubmed_authors><pubmed_authors>Wong FS</pubmed_authors><pubmed_authors>Bai X</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Jia J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blockade of glucagon receptor induces α-cell hypersecretion by hyperaminoacidemia in mice.</name><description>Blockade of the glucagon receptor (GCGR) has been shown to improve glycemic control. However, this therapeutic approach also brings side effects, such as α-cell hyperplasia and hyperglucagonemia, and the mechanisms underlying these side effects remain elusive. Here, we conduct single-cell transcriptomic sequencing of islets from male GCGR knockout (GCGR-KO) mice. Our analysis confirms the elevated expression of Gcg in GCGR-KO mice, along with enhanced glucagon secretion at single-cell level. Notably, Vgf (nerve growth factor inducible) is specifically upregulated in α cells of GCGR-KO mice. Inhibition of VGF impairs the formation of glucagon immature secretory granules and compromises glucagon maturation, lead to reduced α-cell hypersecretion of glucagon. We further demonstrate that activa</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-21T16:55:03.162Z</modification><creation>2025-04-21T16:55:03.162Z</creation></dates><accession>S-EPMC11903786</accession><cross_references><pubmed>40075066</pubmed><doi>10.1038/s41467-025-57786-7</doi></cross_references></HashMap>